Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sofie Deschoemaeker
Observed names:
S Deschoemaeker,
S. Deschoemaeker
Institution:
Vrije Universiteit Brussel
Observed institutions:
Uppsala University,
Vrije Universiteit Brussel,
Vlaams Instituut voor Biotechnologie,
VIB-KU Leuven Center for Cancer Biology,
VIB-VUB Laboratory Myeloid Cell Immunology,
RWTH Aachen University,
KU Leuven
show all 7
ORCID:
0000-0001-5449-282X
Observed ORCID:
0000-0001-5449-282X
OpenAlex ID:
A5045148243
Works
44
Awards
1
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
2013
·
Andrea Casazza
, Damya Laoui
, et al.
·
Cancer Cell
·
647
PDF
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis
2011
·
Yukiji Takeda
, Sandra Costa
, et al.
·
Nature
·
293
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
2013
·
A Casazza
, G Di Conza
, et al.
·
Oncogene
·
255
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity
2012
·
Rodrigo Leite de Oliveira
, Sofie Deschoemaeker
, et al.
·
Cancer Cell
·
125
PDF
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity
2024
·
Ahmed E. I. Hamouda
, Jessica Filtjens
, et al.
·
Nature Communications
·
124
PDF
The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia
2017
·
Giusy Di Conza
, Sarah Trusso Cafarello
, et al.
·
Cell Reports
·
120
PDF
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
2022
·
Emma Verheye
, Jesús Bravo Melgar
, et al.
·
International Journal of Molecular Sciences
·
56
PDF
PHD1 regulates p53‐mediated colorectal cancer chemoresistance
2015
·
Sofie Deschoemaeker
, Giusy Di Conza
, et al.
·
EMBO Molecular Medicine
·
47
PDF
Genetic Deficiency in Plasma Protein HRG Enhances Tumor Growth and Metastasis by Exacerbating Immune Escape and Vessel Abnormalization
2012
·
Sònia Tugues
, Satoshi Honjo
, et al.
·
Cancer Research
·
43
PDF
Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
2022
·
Aarushi Audhut Caro
, Sofie Deschoemaeker
, et al.
·
Cancers
·
37
PDF
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2022
·
Aleksandar Murgaski
, Máté Kiss
, et al.
·
Cancer Research
·
35
PDF
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506
2021
·
Alexander M.A. van der Wiel
, Victoria Jackson-Patel
, et al.
·
Molecular Cancer Therapeutics
·
35
In Vivo Identification of Adducts from the New Hypoxia-Activated Prodrug CP-506 Using DNA Adductomics
2022
·
Morwena J. Solivio
, Alessia Stornetta
, et al.
·
Chemical Research in Toxicology
·
17
Impact of myo‐inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models
2018
·
Ly‐Binh‐An Tran
, Thanh‐Trang Cao‐Pham
, et al.
·
Journal of Cellular and Molecular Medicine
·
13
PDF
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
2023
·
Emile J. Clappaert
, Daliya Kancheva
, et al.
·
Frontiers in Immunology
·
12
PDF
Heterogeneity and function of macrophages in the breast during homeostasis and cancer
2022
·
Eva Hadadi
, Sofie Deschoemaeker
, et al.
·
International review of cytology
·
5
Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells
2026
·
Aarushi A. Caro
, Daliya Kancheva
, et al.
·
Nature Communications
·
4
PDF
Abstract 4959: CP-506, a next generation hypoxia-activated prodrug, as promising novel anti-cancer therapeutic
2018
·
sophie thiolloy
, Sofie Deschoemaeker
, et al.
·
Cancer Research
·
4
Next‐Generation Bio‐Reducible Lipids Enable Enhanced Vaccine Efficacy in Malaria and Primate Models
2025
·
Ruben De Coen
, Sabah Kasmi
, et al.
·
Advanced Functional Materials
·
1
PDF
Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023
·
Aleksandar Murgaski
, Máté Kiss
, et al.
·
1
IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?
2020
·
Sofie Deschoemaeker
, Damya Laoui
·
EBioMedicine
·
1
PDF
EP-2327: Hypoxic cell killing by CP-506, a novel hypoxia-activated prodrug
2018
·
R. Niemans
, A. Yaromina
, et al.
·
Radiotherapy and Oncology
·
1
Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq
2026
·
Pauline M. R. Bardet
, Lize Allonsius
, et al.
·
Nature Communications
PDF
Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023
·
Aleksandar Murgaski
, Máté Kiss
, et al.
Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
2023
·
Aleksandar Murgaski
, Máté Kiss
, et al.
Show more works
View as search
Works count:
44
Citation count:
1,876
H-index:
13
I10-index:
15
Year
Topic
Type
